Overexpression of inactive GSK3β promotes [169], and active GSK3β suppress mammary tumours [168]Active GSK3 increases chemosensitivity, cell cycle arrest and reduces mammary tumorigenecity [170-172]Pharmacological inhibition of GSK3 in breast epithelial causes EMT and invasion [39]. Here, GSK3B is linked to breast cancer.